tirzepatide is wegovy vs. Semaglutide for Weight Loss Wegovy® (semaglutide) vs. Mounjaro® (tirzepatide):

Lilly says it will use the new study, along with results from an earlier study of weight loss in people without diabetes, to ask the US Food and Drug Administration to fast-track approval for tirzepatide purely for weight loss, which would make it a direct competitor to the blockbuster obesity drug Wegovy

Prefer listening

In May 2022, tirzepatide (marketed as Mounjaro) received FDA approval for improving blood sugar control in adults with type 2 diabetes, in combination with diet and exercise

Choose low-sugar, low-calorie alcoholic beverages to avoid post-drink blood sugar spikes (e.g., dry wine, spirits with zero-calorie mixers)

Contamination risk with compounded/DIY products: This is the bigger practical concern

Many patients notice areas of looseness or sagging, and its completely understandable to wonder what can be done